The GLP-1 metabolite (9 – 37) improves myocardial function in the TAC model by reducing myocardial hypertrophy and improving glucose uptake
Julia Möllmann(Universitätsklinikum Aachen), Michael Lehrke(RWTH Aachen University), Nikolaus Marx(RWTH Aachen University), HJ Kaiser(Klinik und Poliklinik für Nuklearmedizin), Felix M. Mottaghy(College Board), J F P Luiken(Maastricht University), J. F.C. Glatz(Maastricht University), AT Vogg(Klinik und Poliklinik für Nuklearmedizin), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Oliver Winz(Klinik und Poliklinik für Nuklearmedizin), Will A. Coumans(Maastricht University), Corinna Lebherz(RWTH Aachen University)
Cited by 0
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
T-lymphocyte Infiltration in Visceral Adipose Tissue
|Arteriosclerosis Thrombosis and Vascular Biology|2008|679
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411